Leor Perl

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Vascular Graft Solutions Ltd. develops a special device to reduce graft failure rate in order to prevent re-do CABG (Coronaly artery bypass grafting) operation and other secondary interventions in coronary patients. The firm has developed the VEST, a novel Venous External STent for vein grafts. The device is kink-resistant external stent which is deployed over the entire vein graft without interfering with or changing the normal course of the CABG procedure. The company was founded by Eyal Orion in 2009 and is headquartered in Tel Aviv, Israel.

Rad Biomed Accelerator Ltd. (Rad Biomed Accelerator) is a venture capital subsidiary of RAD-Bynet Group founded by Yehuda Zisapel and Nava Zisapel in 1992. The firm is headquartered in Tel Aviv, Israel.

Dune Medical Devices Ltd. engages in the development of real-time cancer detection tools. Its products are MarginProbe and Smart Biopsy System. The company was founded by Dan Hashimshony in 2002 and is headquartered in Caesarea, Israel.

FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by Stéphane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France.

Neurocords Corp. is holding company. The company currently does not have any operations. It intends to focus on the development and commercialization of 3-dimensional scaffolds for spinal, optic and peripheral nerve reconstruction and regeneration. The company was founded on September 20, 2018 and is headquartered in Ness Ziona, Israel.

Moebius Medical Ltd. develops mechanical lubricants for reducing joint damage. It develops MM-II, a novel liposome-based bio-lubricant for long-term treatment of osteoarthritis. The company was founded by Yaniv Dolev and Yechezkel Barenholz in 2008 and is headquartered in Tel Aviv, Israel.

Neurim Pharmaceuticals Ltd. is a neuroscience drug discovery and development company. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 by Nava Zisapel and Yehuda Zisapel and is headquartered in Tel-Aviv, Israel.

RapidPulse, Inc. is a medical device company that specializes in developing minimally invasive vascular products for ischemic stroke. The company is based in Miami, FL. The company is focused on advancing the development of the RapidPulse™ cyclic aspiration system, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinout of Syntheon LLC, a medical device incubator dedicated to developing innovative products in the medical device industry. The CEO of the company is Sean McBrayer.

Adient Medical, Inc. develops and manufactures absorbable medical devices. It offers an absorbable vascular filter for the prevention of pulmonary embolism. The company was founded in 2012 and is headquartered in Pearland, TX.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

Aria CV, Inc. develops medical devices. It designed to improve the lives of patients living with the disease of pulmonary hypertension. The company was founded by John Scandurra and Karl Vollmers in 20101 and is headquartered in St. Paul, MN.

AtaCor Medical, Inc. develops cardiac medical devices. The firm offers AtaCor pacing system. The company was founded by Rick Sanghera, Alan Marcovecchio, and Sean McGeehan in 2014 and is headquartered in San Clemente, CA.

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.

Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts.

Body Vision Medical Ltd. operates as a revolutionary platform for lung cancer diagnostics and treatment. The firm’s products include lungvision system and lungvision tool. The company was founded by Dorian Averbuch in 2014 is headquartered in Ramat Ha Sharon, Israel.

Perflow Medical Ltd. manufactures endovascular devices. It develops Stream for the treatment of neurovascular disorders including brain aneurysms. The company was founded by Gilad Cibulski in 2010 and is headquartered in Tel Aviv, Israel.

Champel Capital Ltd. (Champel Capital) is a venture capital firm founded in 2017 by Arie Benguigui and Amir Weitmann. The firm is headquartered in Israel.

Laminate Medical Technologies Ltd. develops systems and tools to improve vascular access patency rates in hemodialysis patients. It offers medical devices, healthtech, nephrology, endovascular, and healthcare. The company was founded by Tammy Gilon and Orion Eyal in 2011 and is headquartered in Tel Aviv, Israel.

Remon Medical Technologies, Inc. develops and commercializes assessment and treatment implants. It has developed applications for patient management, post-operative monitoring, nerve and tissue stimulation and local drug delivery. The company was founded by Eyal Doron, Yariv Porat and Yossi Tzaliach in 1997 and is headquartered in Waltham, MA.